Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Aldurazyme
Active Ingredient: Laronidase 0.58mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Healthcare Logistics
Manufacturer: BioMarin Pharmaceutical Inc, 46 Galli Drive, Novato, California, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 7th day of December 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).